Sirona Biochem Corp.  

(Public, CVE:SBM)   Watch this stock  
Find more results for cve:sbm
0.155
-0.005 (-3.12%)
Aug 26 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.16 - 0.17
52 week 0.09 - 0.20
Open 0.16
Vol / Avg. 297,314.00/1.13M
Mkt cap 18.56M
P/E     -
Div/yield     -
EPS -0.03
Shares 121.54M
Beta -0.52
Inst. own     -

Key stats and ratios

Q1 (Jan '14) 2013
Net profit margin -1816.88% -
Operating margin -1773.86% -
EBITD margin - -
Return on average assets -112.97% -90.35%
Return on average equity -183.42% -141.37%
CDP Score - -

Address

889 Pender St W
VANCOUVER, BC V6C 3B2
Canada
+1-604-6414466 (Phone)
+1-604-6085471 (Fax)

Website links

Description

Sirona Biochem Corp. is a Canada-based, development-stage company. Sirona is a product-pipeline company with a proprietary technology platform developed at its laboratory facility in France. The Company specializes in the stabilization of carbohydrate molecules. The Company�s compounds are being developed for both pharmaceutical and cosmetic marketplaces. It is also focused on advancing three programs: therapeutics, which includes sodium glucose co-transporter (SGLT) and cancer antigen; cosmetic agents, which includes skin lightener and anti-aging and biological ingredients, which includes inducers and adjuvants. Its two most advanced programs include a diabetes treatment and a cosmetic skin lightening agent.

Officers and directors

Howard Verrico M.D. Chairman of the Board, Interim Chief Executive Officer, Founder, Secretary
Christopher D. Hopton Chief Financial Officer, Director
Geraldine Deliencourt-Godefroy Chief Scientific Officer, Director
David S. Moore Director
Michael Rogers Director
Nigel Terrett Director
Alex Marazzi Independent Director